Saturday 17 October 2026 Export HRMY’s income statement to Excel — free account

Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $868.5 million, up 21.5% from fiscal 2024. In the quarter to June 2026, revenue grew 30.3%, EPS grew 88.4%, free cash flow grew 16.5% and total debt fell 10.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five.

38.20 0.07 −0.18%

Follow HRMY

Alert me

Market cap: $2.2B
P/E: 12.2×
Fwd P/E: 9.4×
Dividend yield: —
F-score: 5/9
Altman Z: 5.23
Beneish M: −2.99
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	8.53	13.61	11.12	11.63
P/S ratio Full definition →		1.92	2.48	1.80	2.20
P/FCF ratio Full definition →		6.17	6.99	5.37	6.70
P/Operating CF Full definition →		14.59	17.05	58.34	22.82
P/B ratio Full definition →		1.90	2.47	1.78	2.11
Price to Tangible BV Full definition →		2.14	2.76	1.96	2.29
EV/Sales Full definition →		1.31	1.77	1.27	1.66
EV/EBITDA Full definition →		4.36	6.61	5.31	6.25
EV/Operating CF Full definition →		3.64	4.42	3.33	4.49
EV/FCF Full definition →		4.21	5.00	3.77	5.07
Quick Ratio Full definition →		3.46	3.46	3.45	3.33
Current Ratio Full definition →		3.75	3.60	3.58	3.48
Net Debt/EBITDA Full definition →		(7.07)	(13.34)	(11.16)	(5.41)
Debt/Assets Full definition →		13.95%	12.87%	12.49%	11.21%
Debt/Equity Full definition →		0.20	0.19	0.17	0.15
Asset Turnover Full definition →		0.77	0.76	0.77	0.77
Operating CF/Net income Full definition →		2.14	5.61	0.85	1.23
Capex/Depreciation Full definition →		(0.01)	(0.01)	0.00	0.00
Interest Coverage Full definition →		18.09	10.87	11.53	29.09
Research and Development Expense of Revenue Full definition →		22.95%	20.48%	32.21%	17.83%
Selling, General and Administrative Expense of Revenue Full definition →		24.79%	35.58%	29.81%	23.79%
Intangible Assets out of Total Assets Full definition →		0.08	0.07	0.07	0.06
Share Based Compensation of Revenue Full definition →		4.58%	4.09%	4.93%	3.57%
Graham Net Nets Full definition →		0.29	0.24	0.26	0.21
Graham Number Full definition →		32.47	30.60	29.88	34.85
Earnings Yield Full definition →		11.72%	7.35%	9.00%	8.60%
Free Cash Flow Yield Full definition →		16.20%	14.31%	18.63%	14.92%
Revenue per Share Full definition →		4.16	4.24	3.73	4.51
Operating CF per Share Full definition →		1.89	2.19	0.48	1.60
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		1.89	2.19	0.48	1.60
Cash per Share Full definition →		11.69	13.49	11.08	11.53
Shareholders Equity per Share Full definition →		14.51	15.14	15.74	17.25
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		14.51	15.14	15.74	17.25
Free Cash Flow Full definition →		108.66	126.04	27.76	92.43
Working Capital Full definition →		615.40	654.88	561.48	580.26
Capital Expenditures Full definition →		(0.07)	(0.11)	—	—
Net Current Asset Value Full definition →		465.71	505.60	417.34	440.49
EV/EBIT Full definition →		4.80	7.39	6.00	6.92
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		7.03	10.32	8.55	9.15
Other line items
Average Receivables Full definition →		91.08	89.91	107.10	101.99
Average Payables Full definition →		18.44	15.72	23.03	24.99
Average Inventory Full definition →		6.90	6.28	5.83	6.23
Average Assets Full definition →		1,068.18	1,135.42	1,163.68	1,240.55
Average Common Equity Full definition →		715.96	764.69	815.44	886.16

Fold the line items

Columns are period end dates

Stockrow Weekly